|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.85 USD | -3.59% |
|
+32.75% | +230.21% |
| Jul. 15 | Second malaria vaccine launched in Ivory Coast in new milestone | RE |
| Jul. 02 | Novavax Seeks Health Canada Approval for Updated Covid-19 Vaccine | MT |
By Josh Beckerman
Novavax Inc. submitted a request Monday to the U.S. Food and Drug Administration for Emergency Use Authorization for Covid-19 vaccine candidate NVX-CoV2373, for people 18 and up.
Shares were recently 6% higher at $88.08.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
01-31-22 1404ET
| 1st Jan change | Capi. | |
|---|---|---|
| +230.21% | 2.31B | |
| +24.74% | 47.96B | |
| -0.47% | 42.45B | |
| +43.96% | 41.47B | |
| +25.40% | 31.6B | |
| +17.96% | 28.63B | |
| -4.47% | 28.03B | |
| +50.73% | 14.56B | |
| +42.56% | 14.14B | |
| +1.46% | 12.58B |
NOVAVAX, INC. 
